Symposium 2: Should we treat neuropathy in T2DM differently?

Authors

  • Graciela Fuente Durand Hospital, Dra. Fuente Medical Office, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.493

Keywords:

diabetes mellitus, neuropathy

Abstract

Diabetic neuropathy (DN) belongs to the microvascular complications with a major impact on quality of life and on life expectancy. It is a neurodegenerative disorder that compromises both the somatic and autonomic peripheral nervous systems in the context of Diabetes Mellitus. DN is a very prevalent complication that can be present even in non diabetic dysglycemia stages and Metabolic Syndrome. It requires a sustained intervention, and prevention of its appearance must be attempted.

Regarding management, it is postulated that the optimization of glycemic control is effective as a therapeutic measure in people with T1Diabetes mainly, while the intervention must be multifactorial in patients with T2Diabetes. In this population, changes in lifestyle, with physical exercise and weight loss represent the bases of management for distal and symmetric diabetic polyneuropathy, which is the most frequent clinical form to observe in daily clinical practice. These changes should be implemented early in the course of the disease1.

Author Biography

Graciela Fuente, Durand Hospital, Dra. Fuente Medical Office, Autonomous City of Buenos Aires, Argentina

Diabetes and Nutrition Specialist; Head of the Nutrition Unit

References

I. Cernea S, Raz I. Diabetes: State-of-the-Art 100 years after the discovery of insulin. Special Issue. Edited by S. Polyzos and C. Mantzoros 2021; Vol. 123.

II. Feldman E, Callaghan B, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primer. 2019 Jun 13;5(1):42

III. Stino A, Smith A. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig 2017;Vol. 8,5.

Downloads

Published

2022-09-01

How to Cite

Fuente, G. (2022). Symposium 2: Should we treat neuropathy in T2DM differently?. Journal of the Argentine Society of Diabetes, 56(3Sup), 8–8. https://doi.org/10.47196/diab.v56i3Sup.493

Issue

Vol. 56 No. 3Sup (2022): September/December 2022

Section

Symposium Part 1

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>